Partnership / Collaboration · MENA · Announced 18 Nov 2026

Eva Pharma → Med Right

EVA Pharma signed a cooperation protocol with Egyptian healthcare programme manager Med Right to extend its patient support programmes in cardiometabolic, immunology, oncology, and bone and pain to Med Right's network beneficiaries in Egypt.

Parties: EVA Pharma (Egypt) → Med Right (Egypt)

Value
Undisclosed
Territory
Egypt
Therapeutic area
Multi-therapy
Asset
Patient support programmes
Announced
18 Nov 2026

Our analysis

Why this matters

EVA Pharma and Med Right for Healthcare Program Management announced on 18 November 2026, from Cairo, a cooperation protocol that extends EVA Pharma's patient support programmes (PSPs) to beneficiaries of Med Right's network. The programmes cover cardiometabolic health, immunology, oncology, and bone health and pain management. No financial terms were disclosed.

The protocol also includes continuing medical education and training for physicians and Med Right's case-management teams. Patients already enrolled stay on a programme until the end of their current course of treatment, even if the arrangement is terminated. The parties say they may later look at wellness programmes.

The full analysis is free to read with a work email on this page.

Source: Dawaa News MENA

More deals involving Eva Pharma or Med Right

Latest deals

All MENA deals → · All partnership / collaboration deals → · Browse all emerging-market pharma deals →